A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma

Andrea B. Apolo*, Fatima H. Karzai, Jane B. Trepel, Sylvia Alarcon, Sunmin Lee, Min Jung Lee, Yusuke Tomita, Liang Cao, Yunkai Yu, Maria J. Merino, Ravi A. Madan, Howard L. Parnes, Seth M. Steinberg, Beatriz Walter Rodriguez, Ben K. Seon, James L. Gulley, Philip M. Arlen, Nancy A. Dawson, William D. Figg, William L. Dahut

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences